IntroductionThe transient phosphorylation of proteins on tyrosine residues represents a very common and versatile signaling mechanism regulating several cellular functions. Changes in the tyrosine phosphorylation level of multiple intracellular substrates also occur in circulating blood platelets upon stimulation with virtually all the physiological agonists. 1,2 These include soluble molecules acting on 7 transmembrane G-protein-coupled receptors, such as thrombin or thromboxane A 2 ; adhesive proteins, such as von Willebrand factor (VWF) and collagen, which bind to the peculiar platelet receptors GPIb-IX-V and GPVI, respectively; and integrin ligands, such as fibrinogen, which initiates an outside-in signaling process regulating platelet aggregation and clot retraction. [1][2][3][4][5] The overall level of protein tyrosine phosphorylation and the regulation of the strength and duration of a phosphorylation-based signaling pathway result from the balanced action of protein kinases and phosphatases. While a large repertoire of soluble cytosolic tyrosine kinases has been described in platelets, and has been extensively studied in the past, relatively little information is available on the expression, substrate specificity, and function of protein-tyrosine phosphatases. 6 Only 3 enzymes, of a superfamily including more than 90 members, have been described in platelets: PTP-1B, SHP-1, and SHP-2.PTP-1B is the most abundant phosphatase in platelets, and is activated by calpain-dependent proteolysis or by interaction with the cytoskeleton during integrin ␣IIb3-dependent aggregation. 7,8 Only 2 substrates for PTP-1B have been unambiguously identified in platelets: the adaptor protein LAT and the tyrosine kinase c-Src. 9,10 While the late dephosphorylation of LAT is associated with the negative regulation of platelet activation induced by clustering of the low-affinity receptor for immunoglobulin G, Fc␥RIIA, 9 activation of c-Src by dephosphorylation of Tyr 529 occurs upon fibrinogen binding to platelets, and implicates PTP-1B in the positive regulation of integrin ␣ IIb  3 outside-in signaling. 10 SHP-1 and SHP-2 are SH2 domain-containing tyrosine phosphatases. 11 In thrombin-or collagen-stimulated platelets, SHP-1 interacts with the cytoskeleton and associates with c-Src. 12,13 SHP-1 is activated by tyrosine phosphorylation, and negatively regulated by PKC-directed serine phosphorylation. 14,15 During platelet aggregation, both SHP-1 and SHP-2 can be activated by interaction with the tyrosine-phosphorylated intracellular domain of the membrane receptor PECAM-1. 16 Although many substrates for SH2-containing phosphatases have been identified in nucleated cells, only Vav and ␣-actinin have been demonstrated to be dephosphorylated by SHP-1 in platelets. 15,17 In addition, a reduced, rather than increased, protein phosphorylation has been observed in collagenstimulated platelets from mice expressing a catalytic inactive form of SHP-1, suggesting a positive role in platelet activation. 18 The low-molecular-weight protein...